Voyager Therapeutics, Inc. Income Statement

Income Statement Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -1.95M17.33M14.22M10.13M7.62M104.39M171.13M37.41M40.91M250.01M80.00M
Gross Profit -1.95M17.33M14.22M10.13M7.62M104.39M171.13M37.41M40.91M250.01M80.00M
Operating items
Research & Development 8.90M27.68M42.25M62.26M64.91M119.73M108.75M73.79M60.76M92.17M127.37M
Selling, General & Administrative 5.47M9.91M13.27M19.74M33.81M36.34M34.99M37.25M30.98M35.82M35.92M
Operating Expenses 14.37M37.59M55.52M82.00M98.71M156.07M143.74M111.03M91.74M127.99M163.29M
Operating Income -14.37M-20.25M-41.30M-71.86M-91.09M-51.68M27.38M-73.62M-50.84M122.01M-83.29M
EBIT -14.37M-20.25M-41.30M-71.86M-91.09M-51.68M27.38M-73.62M-50.84M122.01M-83.29M
Non-operating items
Interest & Investment Income -0.00M0.33M0.98M1.23M3.31M6.46M1.66M-0.39M1.79M11.72M18.33M
Other Non Operating Income -1.95M-9.75M0.18M-0.06M-0.68M1.62M7.70M2.81M2.65M0.00M0.62M
Non Operating Income -1.95M-9.75M1.16M1.17M2.63M8.08M9.36M2.81M4.45M11.72M18.95M
Net income details
EBT -16.32M-29.67M-40.14M-70.70M-88.47M-43.60M36.74M-71.20M-46.39M133.74M-64.34M
Tax Provisions 0.05M-0.18M0.02M1.41M0.67M
Profit After Tax -16.32M-29.67M-40.19M-70.70M-88.29M-43.60M36.74M-71.20M-46.41M132.33M-65.00M
Income from Continuing Operations -16.32M-29.67M-40.19M-70.70M-88.29M-43.60M36.74M-71.20M-46.41M132.33M-65.00M
Consolidated Net Income -16.32M-29.67M-40.19M-70.70M-88.29M-43.60M36.74M-71.20M-46.41M132.33M-65.00M
Income towards Parent Company -16.32M-29.67M-40.19M-70.70M-88.29M-43.60M36.74M-71.20M-46.41M132.33M-65.00M
Preferred Dividend Payments 1.37M7.37M1.20M
Net Income towards Common Stockholders -17.68M-38.29M-40.19M-70.70M-88.29M-43.60M36.74M-71.20M-46.41M132.33M-65.00M
Additional items
EPS (Basic) 0.00M0.00M-0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M0.00M-0.00M-0.00M0.00M-0.00M
Shares Outstanding (Weighted Average) 26.75M26.72M26.95M32.56M37.07M37.47M37.96M38.61M44.00M54.63M
EBITDA -16.32M-29.92M-39.99M-70.93M-88.25M-43.57M36.71M-71.20M-46.49M132.50M-65.36M
Tax Rate 0.20%1.05%